← All medicines

Immune and inflammatory medicines

Leniolisib

Independent educational summary · Sources checked November 20, 2026

A kinase inhibitor for eligible activated PI3K-delta syndrome, a genetic immune disorder.

Profile scope: Leniolisib. Confirm the exact product and route; formulations and combination products are not interchangeable.

Possible side effects

Headache, nasal symptoms, skin irritation, diarrhea, fatigue, or body discomfort may occur.

Serious risks and warning signs

The NIH monograph does not provide a separate serious-effects list. Pregnancy, interactions, vaccination, and unexplained fever or fast pulse still require review. Infection and lymphoma risks of APDS should not automatically be attributed to the medicine.

A question for your healthcare team

What response, pregnancy, vaccine, and interaction checks are needed, and which new symptoms should prompt contact?

What to do with this information

Discuss persistent or troubling symptoms with your prescriber or pharmacist. For severe breathing difficulty, collapse, a seizure, or inability to wake someone, seek emergency help. Read the linked medicine information for drug-specific instructions, including situations requiring immediate action. For routine treatment changes, consult your prescriber rather than changing your dose on your own. Follow the urgent action instructions above and in the linked medicine information.

Sources

Sources checked November 20, 2026. An original AI-assisted educational summary, not a complete adverse-effect or interaction list. This profile is part of the broader library expansion, not the original prescription-use ranking. Inclusion does not confirm current product availability or mean that risks outweigh benefits. This page has not been independently reviewed by a clinician.